Ligand identification for G-protein-coupled receptors: a lead generation perspective

被引：36

作者：

Bleicher, KH ^{[1
]}

Green, LG ^{[1
]}

Martin, RE ^{[1
]}

Rogers-Evans, M ^{[1
]}

机构：

[1] F Hoffmann La Roche & Co Ltd, Div Pharmaceut, Lead Generat, PRBDCI, CH-4070 Basel, Switzerland

来源：

CURRENT OPINION IN CHEMICAL BIOLOGY | 2004年 / 8卷 / 03期

关键词：

D O I：

10.1016/j.cbpa.2004.04.008

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

This review addresses strategies for the generation of ligands for G-protein-coupled receptors outside classical high-throughput screening and literature based approaches. These range from the chemical intuition-based strategies of endogenous ligand elaboration and privileged structure decoration to the in silico approaches of virtual screening and de novo design. Examples are cited where supporting pharmacological data has been presented.

引用

页码：287 / 296

页数：10

共 67 条

[1] Integration of virtual and high-throughput screening
Bajorath, F
[J]. NATURE REVIEWS DRUG DISCOVERY, 2002, 1 (11) : 882 - 894
[2] Protein-based virtual screening of chemical databases. II. Are homology models of G-protein coupled receptors suitable targets?
Bissantz, C
Bernard, P
Hibert, M
Rognan, D
[J]. PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS, 2003, 50 (01) : 5 - 25
[3] Parallel solution- and solid-phase synthesis of spiropyrrolo-pyrroles as novel neurokinin receptor ligands
Bleicher, KH
Wüthrich, Y
Adam, G
Hoffmann, T
Sleight, AJ
[J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2002, 12 (21) : 3073 - 3076
[4] Parallel solution- and solid-phase synthesis of spirohydantoin derivatives as neurokinin-1 receptor ligands
Bleicher, KH
Wüthrich, Y
De Boni, M
Kolczewski, S
Hoffmann, T
Sleight, AJ
[J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2002, 12 (18) : 2519 - 2522
[5] Novel inhibitors of DNA gyrase: 3D structure based biased needle screening, hit validation by biophysical methods, and 3D guided optimization. A promising alternative to random screening
Boehm, HJ
Boehringer, M
Bur, D
Gmuender, H
Huber, W
Klaus, W
Kostrewa, D
Kuehne, H
Luebbers, T
Meunier-Keller, N
[J]. JOURNAL OF MEDICINAL CHEMISTRY, 2000, 43 (14) : 2664 - 2674
[6] Ligands for glutamate receptors:: Design and therapeutic prospects
Bräuner-Osborne, H
Egebjerg, J
Nielsen, EO
Madsen, U
Krogsgaard-Larsen, P
[J]. JOURNAL OF MEDICINAL CHEMISTRY, 2000, 43 (14) : 2609 - 2645
[7] Brenner M, 2001, HELV CHIM ACTA, V84, P2155, DOI 10.1002/1522-2675(20010815)84:8<2155::AID-HLCA2155>3.0.CO
[8] 2-8
[9] Design and synthesis of a piperazinylalkylisoxazole library for subtype selective dopamine receptor ligands
Cha, MY
Choi, BC
Kang, KH
Pae, AN
Choi, KI
Cho, YS
Koh, HY
Lee, HY
Jung, D
Kong, JY
[J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2002, 12 (10) : 1327 - 1330
[10] Design and parallel synthesis of piperidine libraries targeting the nociceptin (N/OFQ) receptor
Chen, ZM
Miller, WS
Shan, S
Valenzano, KJ
[J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2003, 13 (19) : 3247 - 3252

← 1 2 3 4 5 6 7 →